FIND and Cepheid, Inc, announced today the launch of the new Xpert MTB/XDR test, which enables expanded drug-resistance TB profiling in less than 90 minutes. Xpert MTB/XDR can be used to empower clinicians to quickly prescribe treatment regimens for extensively drug-resistant TB (XDR-TB).
Please see this link for more information: https://www.finddx.org/newsroom/pr-16jul20/